Top Abstract Purchase Related
Home
>
Node
>
Subnode

Understanding and managing myeloma

Campbell, K.

Nursing Times 110(34-35): 12-15

2014

ISSN/ISBN: 0954-7762
PMID: 25241434
Document Number: 673378
Multiple myeloma cannot be cured and treatment can be complex. This article outlines the pathophysiology of the condition, together with the diagnostic process and the available treatment options.

Document emailed within 1 workday
Secure & encrypted payments

Tran, D.; Sinclair, R.D. 1999: Understanding and managing common baldness Australian Family Physician 28(3): 248-250; 252-253
Brousseau, M.; Manzini, C.; Thie, N.; Lavigne, G. 2003: Understanding and managing the interaction between sleep and pain: an update for the dentist Journal 69(7): 437-442
Chanukuppa, V.; Taware, R.; Chatterjee, T.; Sharma, S.; More, T.H.; Taunk, K.; Kumar, S.; Santra, M.K.; Rapole, S. 2018: Current Understanding of the Potential of Proteomics and Metabolomics Approaches in Cancer Chemoresistance: A Focus on Multiple Myeloma Current Topics in Medicinal Chemistry 18(30): 2584-2598
Levy, B.P.; Rao, P.; Becker, D.J.; Becker, K. 2016: Attacking a Moving Target: Understanding Resistance and Managing Progression in EGFR-Positive Lung Cancer Patients Treated with Tyrosine Kinase Inhibitors Oncology 30(7): 601-612
Hindmarsh, J.; Reynolds, P.; Dunne, S. 2011: Exhibiting understanding: The body in apprenticeship : Understanding understanding in action - Exposition de la compréhension: Le corps dans l'apprentissage Journal of Pragmatics 43(2): 489-503
Hindmarsh, J.; Reynolds, P.; Dunne, S. 2011: Exhibiting understanding: The body in apprenticeship : Understanding understanding in action - Exposition de la compréhension: Le corps dans l'apprentissage Journal of Pragmatics 43(2): 489-503
Dunham, L. 1998: Managing care, managing change, managing information Journal of Ahima 69(4): 48-50
Gouveia, W.A. 1993: The rising cost of pharmaceuticals: understanding and managing the escalating cost of pharmaceuticals in health care institutions. Executive summary American Journal of Hospital Pharmacy 50(8 Suppl. 4): S2-S3
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2012: Managing a food web impacts on small mammals of managing grasslands for breeding waders Animal Conservation aop(aop)
Pasqualetti, P.; Casale, R.; Collacciani, A.; Colantonio, D. 1989: Evaluation of a morphologic staging method (myeloma progression score) in multiple myeloma Medicina 9(3): 280-282
Barlogie, B.; Alexanian, R. 1989: Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma Cancer Research 49(24 Pt 1): 7172-7175
Leinonen, P.; Somer, T. 1988: Light-chain myeloma and non-secretory myeloma--problems in di- agnosis and associated paraproteins Duodecim; Laaketieteellinen Aikakauskirja 104(18): 1466-1470
Wu, M-Jei.; Fang, H-Chang.; Chang, T-Yuan.; Lo, Y-Shing.; Chung, H-Min. 2002: Multiple myeloma with myeloma nephropathy in a patient with Hashimoto's thyroiditis Journal of the Formosan Medical Association 101(6): 421-424
Stewart, G.J.; Irvine, S.S.; Scott, M.; Kelleher, A.D.; Marriott, D.J.; McKnight, I.; Pethebridge, A.M.; Wodak, A.; Ziegler, J. 1996: Managing HIV. Part 1: Principles. 1.2 Strategies of care in managing HIV Medical Journal of Australia 164(2): 99-104
G.Mead, P.; H.D. Carr-Smith; M.Drayson, T.; A.R. Bradwell 2003: Detection of Bence Jones Myeloma and Monitoring of Myeloma Chemotherapy UsingImmunoassays Specific for Free Immunoglobulin Light Chains Clinical Laboratory 49(1-2): 25-27
García Laraña, J.; Díaz Mediavilla, J.; Martínez, R.; Lahuerta, J.J.; Alegre, A.; Odriozola, J.; Sureda, A.; San Miguel, J.; De la Rubia, J.; Escudero, A.; Conde, E.; Bladé, J.; Cabrera, R.; Gastearena, J.; Besalduch, J.; Vidal, M.J.; Hernández, F.; Rifon, J.; Leon, A.; Mataix, R.; Parody, R.; Moraleda, J.M.; Solano, C.; de Pablos, J.M.; Sánchez, J.J. 1997: Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma Sangre 42(Suppl 1): 38-41
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Teunissen, L.L.; Notermans, N.C. 1998: The risk of Kahler disease (multiple myeloma) in patients with a paraproteinemia: myeloma risk score, developed in the region of the Integral Cancer Center, West Nederlands Tijdschrift Voor Geneeskunde 142(43): 2374-2375
Takahashi, T.; Makiguchi, Y.; Hinoda, Y.; Kakiuchi, H.; Nakagawa, N.; Imai, K.; Yachi, A. 1994: Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient Journal of Immunology 153(5): 2102-2109
Assaf, M.E.; Pizzolato, M.A.; De María, H.E.; Gasparini, S.; Burucua, J.E. 1983: IgM myeloma Sangre 28(5): 642-647